about
Appendiceal neuroendocrine neoplasms: diagnosis and managementHyperandrogenism after menopauseLong-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study.Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.Inflammatory process in type 2 diabetes: The role of cytokines.Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?Antithyroid drug-induced aplastic anemia.Isolated adrenocorticotropin deficiency and flexion contractures syndrome.Metastatic type 1 gastric carcinoid: a real threat or just a myth?Corticomedullary mixed adrenal tumor: case report and literature review.The ectopic ACTH syndrome.Medical therapy of Cushing's disease: where are we now?Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease.Is urinary free cortisol of value in the diagnosis of Cushing's syndrome?Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.Aggressive pituitary tumors.Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.Association between chronic pelvic pain symptoms and the presence of endometriosis.Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with β-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine.The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center.Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?Primary hyperparathyroidism in patients with gastric carcinoid tumors type 1: an unusual coexistence.Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.Endocrinopathies and other disorders inducing a polycystic ovary syndrome phenotype.Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.The acute effect of Orlistat on dietary glycotoxins in diabetics and healthy women.Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria.IGF-IEc expression is increased in secondary compared to primary foci in neuroendocrine neoplasms.Cardiovascular risk factors in adult patients with multisystem Langerhans-cell histiocytosis: evidence of glucose metabolism abnormalities.Management of neuroendocrine tumors of unknown primary.Association of skin autofluorescence with arterial properties: A closer look at AGE Reader and EndoPAT 2000 commercial devices.Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.Oncogene-induced senescence in pituitary adenomas and carcinomas.Leptin Involvement in Primary Brain and Pituitary Tumors: Therapeutic Potential, Prognostic Value, and Proposed Diagnostic Application.Acetyl Cholinesterase Inhibitors and Cell-Derived Peripheral Inflammatory Cytokines in Early Stages of Alzheimer's Disease.Effects of low-dose metformin and rosiglitazone on biochemical, clinical, metabolic and biophysical outcomes in polycystic ovary syndrome.Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma.
P50
Q26781673-E854B3CE-8139-4847-BCB9-4192988939A5Q26822584-1764985A-4320-496B-938E-0CD4F1E3E277Q30576503-9226720D-3C5B-45CC-AC9C-732849B338B1Q33606047-FEAC1515-9197-4890-B90E-7F67DB646559Q36675862-D5C2CD2B-096B-439A-84AF-1D6AE101D15DQ36921072-6921FEDC-8823-45CE-A0B7-C4A30232060CQ37279047-6D9C8B07-AD5F-46AA-B72C-8D7129738F6FQ37362002-4B6915F3-1743-4F09-9E85-6C737792E7AEQ37408868-190EAE85-A58F-4B21-822C-29A23B112277Q37491975-4B13C129-071D-444A-AF41-8C55986C92E7Q37764738-C3F8CAC1-76D4-482C-B235-D1B633DB2953Q37771170-D8C2EC1C-8BDC-4637-AE7C-0A920B9108C2Q37839521-A8E5867B-CBD8-4107-AA9F-467C6AE9909AQ37890828-E96DE52A-D221-4EBE-812F-DB61AAF3D137Q37962416-3B8BC8BC-4128-475E-8FED-96BEE1FA6471Q38205916-CBD65E27-CDB0-40B1-A4CC-9BA71DE6E9DAQ38311673-766D3B65-5DC4-4C54-B73F-98713F8853D6Q38718807-AEBB5FF1-E4CE-4618-8639-6E8C04C0D3A3Q39088498-B5C2B536-E381-4F13-BABA-D3D92FECB184Q41432904-F97CB6E5-2FC4-44B9-AF4B-23EF363422F2Q42212979-C77FF66D-A0FC-4639-A0BE-30167745466CQ43120453-1A940243-33C4-4B87-B269-7321B08EF7E5Q43647571-A79E0494-9181-4078-9AD1-B9EA515CE5D9Q44264153-203E997E-2E77-4AB2-9B1B-6A585C283C47Q44319723-EEDEBD79-BA8B-4975-AEA5-7E0E33DD1156Q45338777-17C71C9E-AFA1-462A-9C53-0F22C3AD3001Q45929930-3F2CB150-696E-4B2C-81AC-3186FF3FD4D7Q45994614-615A7744-C82B-4006-9585-A645D7B3A2DAQ45995594-4B0641D4-903B-40AF-AE9F-C18D795E9E21Q46491874-E869305B-68DC-47B7-B307-5211D6A14009Q46579680-8B1D8EFC-FB5F-433F-AFD3-0C7A9807D3E8Q46832372-38243C00-8AA4-4FE4-ACBF-667ACE04D7B3Q47589718-50F6E38A-5DFD-411F-A9CC-A5B80E5EB71FQ47703192-EBE594E5-B16A-4F56-8591-99BA12677CD5Q47724538-9D23534D-8868-49BD-BE30-0C82038DC303Q48403605-16BBBCBF-103A-49E4-945F-043F4B78A6D4Q49721466-2A16D742-68CA-45E5-AE87-A6F6D2783256Q50115368-7D8239F8-3716-4D48-890E-65C60E659C00Q51344079-A5BBFCB0-884C-41E7-8B33-AF32B6110D62Q53136461-B662A18E-B4C5-4AB6-B115-D83E40B18B1D
P50
description
researcher ORCID ID = 0000-0003-2398-6768
@en
wetenschapper
@nl
name
Krystallenia I Alexandraki
@ast
Krystallenia I Alexandraki
@en
Krystallenia I Alexandraki
@es
Krystallenia I Alexandraki
@nl
type
label
Krystallenia I Alexandraki
@ast
Krystallenia I Alexandraki
@en
Krystallenia I Alexandraki
@es
Krystallenia I Alexandraki
@nl
prefLabel
Krystallenia I Alexandraki
@ast
Krystallenia I Alexandraki
@en
Krystallenia I Alexandraki
@es
Krystallenia I Alexandraki
@nl
P1153
6505978901
P31
P496
0000-0003-2398-6768